UNSPSC 51391736: Racephedrine

This classification denotes an alpha-adrenergic agonist with the molecular formula C10H15NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03VRY66076, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but generally known as racephedrine, which bears US NIH Compound Identifier 5032. European Medicines Agency schedules Racephedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10237MIG.

UNSPSC 51391736 Racephedrine is a Commodity code that does not align with the recent state and local opportunities tagged to it. Seminole County, Florida's IFB60459723LAS solicits naloxone and drug deactivation systems for community health support, while the Texas Health and Human Services Commission's RFI HHS0017013 explores direct-to-manufacturer prescription fulfillment arrangements. Neither opportunity involves racephedrine procurement. The code shows little relevant recent activity under its nominal pharmaceutical scope.

The mismatch between the code's designation and the work actually being solicited suggests that state and local procurement offices may be applying the racephedrine code inconsistently or that the opportunities were tagged during intake without close alignment review. Racephedrine itself—a sympathomimetic amine used in nasal decongestants and other pharmaceutical preparations—does not appear in the substance or ingredient specifications of either the naloxone/drug-deactivation purchase or the pharmacy benefit direct-contracting exploration. Business development professionals evaluating this code should treat the recent-opportunity signals as unreliable for forecasting racephedrine demand at state and local level and seek direct outreach to health department, corrections, and pharmacy procurement offices in Florida and Texas to validate actual purchasing patterns.